Response to letter from the editor 'Complement C3 activation in cyst fluid and urine from autosomal dominant polycystic kidney disease patients'

Journal of Internal Medicine

Volumn 276, Issue 5, 2014, Pages 541-542

  Su, Z ^a,c   Wuthrich R P ^b   Mei, C ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; COMPLEMENT COMPONENT C3; KI 67 ANTIGEN; LIGAND; PROTEOME; ROSMARINIC ACID;

AUTOSOMAL DOMINANT DISORDER; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CYST FLUID; DNA POLYMORPHISM; EPITHELIUM CELL; HUMAN; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LETTER; MALE; MOUSE; NONHUMAN; RAT; TISSUE REPAIR; URINE; ANIMAL; COMPLEMENT ALTERNATIVE PATHWAY; IMMUNOLOGY;

ANIMALS; COMPLEMENT PATHWAY, ALTERNATIVE; HUMANS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 84911441508     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12306     Document Type: Letter

References (6)

1. Su Z, Wang X, Gao X et al. Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J Intern Med, 2014; 276: 470-85.
2. Bakun M, Niemczyk M, Domanski D et al. Urine proteome of autosomal dominant polycystic kidney disease patients. Clin Proteomics 2012; 9: 13.
3. Lai X, Bacallao RL, Blazer-Yost BL, Hong D, Mason SB, Witzmann FA. Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin Appl 2008; 2: 1140-52.
4. Mrug M, Zhou J, Mannon RB. C3 polymorphisms and outcomes of renal allografts. N Engl J Med 2009; 360: 2477-8.
5. Zhou J, Ouyang X, Schoeb TR et al. Kidney injury accelerates cystogenesis via pathways modulated by heme oxygenase and complement. J Am Soc Nephrol 2012; 23: 1161-71.
6. Swenson-Fields KI, Vivian CJ, Salah SM et al. Macrophages promote polycystic kidney disease progression. Kidney Int 2013; 83: 855-64.